Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECUKINUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 58,471 adverse event reports in the FDA FAERS database where SECUKINUMAB was used for Psoriasis.

Most Reported Side Effects for SECUKINUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 27,434 18.1% 1,304 2,864
Psoriasis 21,976 14.5% 444 2,289
Pain 15,244 10.1% 1,659 3,575
Arthralgia 13,769 9.1% 1,652 3,157
Fatigue 9,406 6.2% 1,796 3,142
Psoriatic arthropathy 8,900 5.9% 1,846 2,614
Pruritus 8,755 5.8% 1,088 1,921
Malaise 8,570 5.7% 1,593 3,029
Rash 8,023 5.3% 1,814 2,489
Condition aggravated 7,536 5.0% 1,526 2,225
Diarrhoea 7,131 4.7% 1,522 2,578
Nasopharyngitis 7,022 4.6% 1,438 2,092
Pain in extremity 6,700 4.4% 1,059 1,874
Headache 6,344 4.2% 1,496 2,466
Joint swelling 5,700 3.8% 1,761 2,440

Other Indications for SECUKINUMAB

Product used for unknown indication (42,781) Psoriatic arthropathy (38,507) Ankylosing spondylitis (12,393) Rheumatoid arthritis (3,334) Hidradenitis (1,484) Axial spondyloarthritis (924) Pustular psoriasis (317) Spondylitis (257) Arthritis (226) Spondyloarthropathy (172)

Other Drugs Used for Psoriasis

APREMILAST (76,127) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628) HUMIRA (6,346)

Related Pages

SECUKINUMAB Full Profile All Psoriasis Drugs SECUKINUMAB Demographics SECUKINUMAB Timeline